Brainstorm Cell Therapeut... (BCLI)
NASDAQ: BCLI
· Real-Time Price · USD
1.06
-0.03 (-2.75%)
At close: Jun 27, 2025, 3:59 PM
1.08
1.41%
After-hours: Jun 27, 2025, 05:53 PM EDT
Brainstorm Cell Therapeutics Stock Forecast
Stock Price Forecast
The 1 analysts with 12-month price forecasts for BCLI stock have an median target of 30, with a low estimate of 30 and a high estimate of 30. The median target predicts an increase of 2730.19% from the current stock price of 1.06.
Latest Analyst Insight Report
According to 1 stock analyst, the rating for Brainstorm Cell Therapeutics Inc. is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.
Financial Forecast this Year
Revenue This Year
258M
from 849K
Increased by 30.29K%
Revenue Next Year
426.9M
from 258M
Increased by 65.5%
EPS This Year
-1.6
from 2.19
Increased by 26.9%
EPS Next Year
-0.93
from -1.6
Increased by 41.9%